Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • March 31, 2023, 23:50 UTC
  • 41

New SEC Filing for (CIK:0001061027)

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • March 31, 2023, 23:50 UTC
  • 38

New SEC Filing for Viracta Therapeutics Inc. (NASDAQ:VIRX)

Comment Full text

Vyant Bio Inc. (VYNT)

  • Company Report
  • March 31, 2023, 23:45 UTC
  • 39

New SEC Form for Vyant Bio, Inc.

Comment Full text

Greenwich LifeSciences Inc. (GLSI)

  • Company Report
  • March 31, 2023, 23:45 UTC
  • 39

New SEC Form for Greenwich LifeSciences, Inc.

Comment Full text

Oragenics Inc. (OGEN)

  • Company Report
  • March 31, 2023, 23:39 UTC
  • 39

New SEC Form for Oragenics, Inc.

Comment Full text

Motus GI Holdings Inc. (MOTS)

  • Company Report
  • March 31, 2023, 23:34 UTC
  • 43

New SEC Form for Motus GI Holdings, Inc.

Comment Full text

Kintara Therapeutics Inc. (KTRA)

  • Company Report
  • March 31, 2023, 23:30 UTC
  • 39

New SEC Form for Kintara Therapeutics, Inc.

Comment Full text

NightHawk Biosciences Inc. (NHWK)

  • Company Report
  • March 31, 2023, 23:30 UTC
  • 41

New SEC Form for Nighthawk Biosciences, Inc.

Comment Full text

Fortress Biotech Inc. (FBIO)

  • Company Report
  • March 31, 2023, 23:20 UTC
  • 38

New SEC Form for Fortress Biotech, Inc.

Comment Full text

BioSig Technologies Inc. (BSGM)

  • Company Report
  • March 31, 2023, 23:20 UTC
  • 42

New SEC Form for BioSig Technologies, Inc.

Comment Full text
  • Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next

Search

News categories

  • Technical Exchange News(9040)
  • Event(407)
  • SEC News(142696)
  • FDA Approval(8415)
  • Company Report(721)
  • Business News(99959)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin